🇺🇸 FDA
Company

Finch

Finch Therapeutics Group

FNCHQ biotech USA

Quick answer

Finch is a biotech company (FNCHQ) headquartered in BOSTON, MA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

CP101

Recurrent C. Difficile Infection

Phase 3 · mab · terminated

1 trials project

CP101

Autism Spectrum Disorder

Phase 2 · small_molecule · terminated

1 trials project

CP101

Clostridium Difficile Infection

Phase 2 · mab · completed

1 trials project

Full Spectrum Microbiota

Clostridium Difficile Infection Recurrence

Phase 2 · small_molecule · completed

1 trials project

Fecal Microbiota Transplantation

Enterobacteriaceae Infections

Phase 1 · mab · terminated

1 trials

Patents (8)

patent

US 12390496

Methods for treating ulcerative colitis

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350298

Microbiome related immunotherapies

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12290538

Methods and products for treatment of gastrointestinal disorders

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12285447

Methods and compositions for treating ulcerative colitis

Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12161678

Compositions for fecal floral transplantation and methods for making and using t

Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12005086

Microbiome related immunotherapies

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11911419

Compositions and methods for treating epilepsy and related disorders

Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11890307

Compositions for fecal floral transplantation and methods for making and using t

Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)